Half of the world is starting to consider the pandemic coming to an end. The other half, the poorer half, can’t afford access to the vaccine and won’t start vaccinating till 2023.
The phrase “None of us is safe until all of us are safe” couldn’t be more true when we live in such an interconnected world trying to fight a virus that can mutate and respread, even to those who are protected.
So we’re talking to Robbie Lawlor from Access to Medicines Ireland about the importance of equitable access to not just COVID 19 vaccines, but to patented medicines across the board. How do medical IP’s work, how do they hold back innovation and what can we do to ensure fair access to medicines for people who need it.